CFO Robert C. Goeltz II Sells Shares in Arcus Biosciences

Robert C. Goeltz II, the Chief Financial Officer of Arcus Biosciences, Inc., sold 5,000 shares of common stock on October 28, 2025, at a price of $20 per share. This transaction was executed under a Rule 10b5-1 trading plan adopted on March 7, 2023. Following the sale, Goeltz II owns 92,138 shares of the company's common stock. The sale was reported in a Form 4 filing with the SEC.